Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/fbffdb96-6605-4c75-a92b-ecbfdce86d82/
UTHR
United Therapeutics CorporationSnapshot 2026-07-26 · 0.9w · Fresh
Strategy Eligibility
5 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 22%
📈
Consistent Earners
Yes
🌱
GARP
✗
🔄
Shareholder Yield
8.7%
💰
High Yield
✗
🚀
Momentum Leaders
12-1 78%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
RAM 2.00
V
Value Analysis
Cheapness relative to fundamentals
23.0%ile
P/E
20.4×
P/S
8.3×
P/B
4.5×
E/P
0.0643
FCF Yield
0.083
EBITDA/EV
0.068
SH Yield
0.087
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
87.00000000
/100 — 1=cheapest
VC2 (Trending Value)
76.00000000
/100
VC3 (Buyback)
78.00000000
/100
FCF yield of 8.3% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
98.0%ile
ROE
0.218
ROA
0.192
Net Margin
0.406
Op Margin
0.513
GPA
0.409
D/E
0.14
Current
4.79
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.059
Earn Growth
0.063
Stability
0.095
lower=better
Accruals
-0.041
lower=better
5yr Consist
Yes
ROE of 22% is exceptional. Conservative balance sheet with D/E of 0.14.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
91.0%ile
6M Return
12.7%
12M Return
73.6%
12-1 Mom
78.2%
Risk-Adj
2.00
Vol 252d
39.1%
Vol 60d
53.5%
↑ Expanding
Max DD 12M
-10.2%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 78% is very strong — a clear uptrend. Risk-adjusted momentum of 2.00 is excellent — strong returns relative to volatility. Near-term vol (53%) is expanding vs long-term (39%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.7
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
7.8%
Sector Quality %ile
99.4%
P/E z-score
-0.12
P/B z-score
-0.10
Sector Avg OS
64.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality Momentum — Expensive
Strong quality (98th) and momentum (91th) but expensive (23th value). Premium priced — watch for mean reversion.
Strong Capital Return
Shareholder yield 8.7% backed by 8.3% FCF yield. Returns are well-funded.
Quality at a Premium
High quality (98th) but expensive (23th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (53%) significantly exceeds 252-day (39%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
58.5% avg (7 factors)
Quality
A
89.1% avg (8 factors)
Momentum
A
82.1% avg (4 factors)
Risk
C
51.5% avg (1 factors)
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.700 | —8 | — | |
| Value %ile | 0.230 | —1 | — | |
| Quality %ile | 0.980 | —8 | — | |
| Momentum %ile | 0.910 | —8 | — | |
| F-Score | 7.000 | —8 | — | |
| Confidence | 0.929 | —8 | — | |
| Volatility | 0.391 | —0 | — |
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
20.44
Earnings Yield (E/P)
0.0643
Price / Sales
8.30
Price / Book
4.46
Price / Cash Flow
16.84
FCF Yield
8.3%
EBITDA / EV
6.8%
Sales Yield (1/P·S)
0.1254
Shareholder Yield
Div + net buyback / mktcap
8.7%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
21.8%
Return on Assets
19.2%
Net Margin
40.6%
Operating Margin
51.3%
Gross Profit / Assets
Novy-Marx GPA
40.9%
Debt / Equity
0.14
Current Ratio
4.79
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.041
External Financing
Net issuance — lower=better
0.410
MomentumPrice trend strength over different horizons
6M Return
12.7%
12M Return
73.6%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
78.2%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
2.00
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
5.9%
Earnings Growth (YoY)
6.3%
Earnings Stability (CV)
Lower = more stable
0.095
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Buyback Yield
8.7%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
87
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
76
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
78
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity